MarketScreener lists USD 3.40 average target for Pulmonx stock

Published on 10/20/2026 at 20:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pulmonx Q2 revenue reached USD 22.76 million, while net loss was USD 10.08 million. Pulmonx stock costs EUR 1.65 on October 20, 2026 after hours.

Analyst target and reporting date

MarketScreener listed a USD 3.40 average target from five analysts on October 13, 2026.
Pulmonx reported USD 22.76 million in second-quarter 2026 revenue and a USD 10.08 million net loss.
Pulmonx stock costs EUR 1.65 at Lang & Schwarz on October 20, 2026 at 8:05 p.m. CEST.
Pulmonx plans to release third-quarter 2026 results on October 27, 2026.

PULM, US7458481014, Illustration mit AI erstellt.

MarketScreener listed a USD 3.40 average target from five analysts for Pulmonx on October 13, 2026. That target is 84.78 percent above the USD 1.84 Nasdaq quote at 2:08 p.m. ET on October 20, 2026. The euro quote stood at EUR 1.65 at Lang & Schwarz on October 20, 2026 at 8:05 p.m. CEST.

Revenue reached USD 22.76 million

Pulmonx reported USD 22.76 million in revenue for the second quarter of 2026, compared with a consolidated net loss of USD 10.08 million. Yahoo Finance identified the same period as Q2 FY26 and showed a profit margin of minus 44.30 percent.

Nasdaq quote remains below yearly high

The Nasdaq quote of USD 1.84 on October 20, 2026 was 36.33 percent below the USD 2.89 52-week high and 62.83 percent above the USD 1.13 52-week low. Pulmonx had a market capitalization of USD 79.0 million at the same market-data timestamp, while trading volume stood at 42,294 shares.

What does the target imply?

The USD 3.40 average target represents an 84.78 percent premium to the USD 1.84 Nasdaq quote, using the same currency and date. MarketScreener listed five analysts and the USD 3.40 average target on October 13, 2026. The figure is a published consensus measure, not a forecast made in this report.

October 27 results date

Pulmonx plans to release its third-quarter 2026 financial results after the close on October 27, 2026, followed by a conference call at 4:30 p.m. ET. The company identifies Nasdaq as its listing venue and LUNG as its ticker on its investor-relations page. The upcoming report will provide the next periodized update after the second-quarter revenue of USD 22.76 million.

Two currencies frame the quote

The Nasdaq quote and the euro quote describe separate venues and currencies. At Lang & Schwarz, Pulmonx stood at EUR 1.65 on October 20, 2026 at 8:05 p.m. CEST, while the Nasdaq quote was USD 1.84 at 2:08 p.m. ET on the same date. The further course of trading is shown by the continuously updated real-time quote of Pulmonx stock.